Abstract:Background: Obesity and type 2 diabetes are strongly associated pathologies, currently considered as a worldwide epidemic problem. Understanding the mechanisms that drive the development of these diseases would enable to develop new therapeutic strategies for their prevention and treatment. Particularly, the role of the brain in the energy and glucose homeostasis has been studied for two decades. In specific, the hypothalamus contains well-identified neural networks regulating appetite and potentially also glucose homeostasis. A new concept has thus emerged, suggesting that obesity and diabetes could be due to a dysfunction of the same, still poorly understood, neural networks. Summary: The neuropeptide 26RFa (also termed QRFP) belongs to the family of RFamide regulatory peptides and has been identified as the endogenous ligand of the human G protein-coupled receptor GPR103 (QRFPR). The primary structure of 26RFa is strongly conserved during vertebrate evolution, suggesting its crucial roles in the control of vital functions. Indeed, the 26RFa/GPR103 peptidergic system is reported to be involved in the control of various neuroendocrine functions, notably the control of energy metabolism in which it plays an important role, both centrally and peripherally, since 26RFa regulates feeding behavior, thermogenesis and lipogenesis. Moreover, 26RFa is reported to control glucose homeostasis both peripherally, where it acts as an incretin, and centrally, where the 26RFa/GPR103 system relays insulin signaling in the brain to control glucose metabolism. Key Messages: This review gives a comprehensive overview of the role of the 26RFa/GPR103 system as a key player in the control of energy and glucose metabolism. In pathophysiological context, this neuropeptidergic system represents a prime therapeutic target whose mechanisms are highly relevant to decipher.

Structure and dynamics of the pyroglutamylated RF-amide peptide QRFP receptor GPR103

Structural basis for recognition of 26RFa by the pyroglutamylated RFamide peptide receptor

N-glycosylation of the human neuropeptide QRFP receptor (QRFPR) is essential for ligand binding and receptor activation

Structures of Human Gastrin-Releasing Peptide Receptors Bound to Antagonist and Agonist for Cancer and Itch Therapy.

Molecular mechanism of prolactin-releasing peptide recognition and signaling via its G protein-coupled receptor

Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein

Identification, localization, and function of a novel avian hypothalamic neuropeptide, 26RFa, and its cognate receptor, G protein-coupled receptor-103

Phase-plate Cryo-Em Structure of a Class B GPCR–G-protein Complex

Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

The 26RFa (QRFP)/GPR103 neuropeptidergic system: A key regulator of energy and glucose metabolism

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

QRFP and GPR103 in the paraventricular nucleus play a role in chronic stress-induced depressive-like symptomatology by enhancing the hypothalamic-pituitary-adrenal axis

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2

Crystal Structure of the Extracellular Domains of GPR110

Structure and Drug Development of the Human Formylpeptide Receptors FPR1 and FPR2.

Structure and dynamics of the CGRP receptor in apo and peptide-bound forms

Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide

Structure-activity relationship studies of tetrahydroquinolone derivatives as GPR41 modulators

Free fatty acid receptors beyond fatty acids: A computational journey to explore peptides as possible binders of GPR120

Development of potent antagonists for formyl peptide receptor 1 based on Boc-Phe-D-Leu-Phe-D-Leu-Phe-OH